Does a routine strategy of rhythm control reduce death from cardiovascular causes in patients with atrial fibrillation and congestive heart failure?
A routine rhythm-control strategy does not reduce cardiovascular mortality compared to rate control in patients with concurrent atrial fibrillation and congestive heart failure.
In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)
Roy et al. (2008) studied this question.